Periodontal disease in dogs and cats presents in many variations. Unfortunately, no one solution exists for all presentations.
I reviewed suprabony (above the alveolar crestal bone) pocket care for stage 2 and 3 periodontal pockets in the January 2012
issue. In this article, I address defects below the alveolar crest.
What are intrabony pockets?
An intrabony, or infrabony, pocket occurs when the bottom of the defect is apical (toward the root) of the alveolar crest.
This most commonly occurs in the interdental area. Food remnants, leukocytes, plaque-covered calculus, desquamated epithelial
cells, serum and fibrin reside in these intrabony defects (Photo 1). Why some dogs and cats develop suprabony defects and
others intrabony defects is unknown, but it is probably related to tooth anatomy and position, which contribute to food impaction
and plaque accumulation.
Photo 1: The typical appearance of intrabony angular (vertical) bone loss along the distal root of a mandibular premolar.
(Photos courtesy of Dr. Jan Bellows)
The intrabony pocket can be further described by the number of remaining osseous walls surrounding the tooth. A direct relationship
exists between the prognosis of therapy and the number of intact walls. Three-walled defects typical with palatal pockets
render the best prognosis for new attachment, followed by two-walled defects. One-walled or no wall defects carry a poor prognosis.
Your treatment options
A primary goal of periodontal surgery is pocket elimination. When faced with an intrabony defect, your treatment choices include
performing an extraction, decreasing the size of the defect through flap exposure followed by apical flap reposition or filling
the defect to decrease pocket depth.
Intrabony filling strategies include:
- Removing the intrabony pathological contents with a curette, followed by gingivectomy
- Using a bone replacement graft to fill the cleaned intrabony defect
- Using guided tissue regeneration with or without bone implant material, which involves using a membrane to selectively allow
bone and periodontal ligament cells to regenerate the defect
- Placing enamel matrix proteins—use of these proteins and various growth factors is still under human dental investigations
with controversial results.
Keep in mind that curettage alone for removal of the pocket contents and gingivectomy to decrease the pocket depth often results
in decreased pocket size but in most cases will allow periodontal disease to progress. After curettage, a clot is formed that
initially occupies the cleaned intrabony defect. Soon the clot is replaced with granulation tissue and junctional epithelium.
This tissue will decrease the pocket size but, unfortunately, there is no real new attachment of the tooth to the alveolus.
Bone replacement grafts
Bone grafts can be successfully used to preserve or restore the alveolar height in deep, narrow, three-walled intrabony pockets,
such as palatal defects, that do not extend into the nasal cavity. With stringent postsurgical home care, the bone grafts
help restore normal bony architecture, rebuild the periodontal ligament and soft tissue and prevent further periodontal pocket
The grafts increase bone level, increase clinical attachment level and reduce probing pocket depths when compared with open
flap débridement procedures alone. Bone replacement grafts should not be attempted on teeth with mobility stage 3 or furcation
exposure or in patients that have significant comorbid factors that would affect healing such as poorly controlled diabetes
mellitus and end-stage renal disease.
There are many options to select from when choosing bone graft material, including autografts (also called autologous, autoplastic,
autogeneic or autogenous grafts), allografts (also called homografts or allologous, allogeneic, allogenous, homologous, homoplastic,
homogeneic or homogenous grafts) and alloplasts.
Autograft: Bone autograft is harvested from a patient's hip or adjacent jaw bone. The advantage is that the tissue is already there.
Disadvantages include increased surgical time, increased discomfort and insufficient amount of harvested graft tissue.
Allograft: Bone allograft is natural bone taken from a donor cadaver of the same species as the intended recipient patient. Human hospital
bone and tissue banks are established as the go-to resource for allograft tissues including musculoskeletal (bone, cartilage,
tendons, fascia), cardiovascular, ocular and skin grafts. Osteoallograft Periomix (Veterinary Transplant Services) is specifically
formulated for veterinary use.
Alloplast: Bioglass (Consil—Nutramax) is bioactive glass made from calcium salts, phosphate, sodium salts and silicon. The addition of
silicon allows for the formation of a silica gel layer over the bioactive glass particles. This layer promotes formation of
a hydroxycarbonate-apatite layer onto which osteoblasts are said to proliferate and form bone (osteoconduction).
In a 1999 study, freeze-dried demineralized canine cadaver bone graft was superior to bioactive glass granules in the treatment
of intrabony defects in Beagles.1 Bone allograft contains bone morphogenetic proteins (BMPs) that stimulate osteoprogenitor cells in the patient's local periosteum
to differentiate into osteoblasts. This process is known as osteoinduction. Inert alloplast synthetic material does not contain proteins helpful to promote bone growth. Synthetic materials commonly
used by veterinarians do not contain BMPs. They do provide an inert scaffold for the host bone to slowly grow onto as long
as the environment remains favorable. Within weeks to months, the inert alloplast material dissolves whereas the bone allograft
integrates with the patient's own bone through the normal bone remodeling process.